Sentence examples for I expressing from inspiring English sources

The proposed method expresses the output in a hierarchical order of component functions which facilitate (i) expressing the component functions in term of extended bases, (ii) determination of actual responses at quasi-random sample points, (iii) determination of the unknown coefficients associated with the bases by employing homotopy algorithm and (iv) Monte Carlo simulation.

In this paper, we analyze typical online performance prediction scenarios and propose a performance meta-model for (i) expressing and resolving parameter and context dependencies, (ii) modeling service abstractions at different levels of granularity and (iii) modeling the deployment of software components in complex resource landscapes.

The impact of accumulating gaps and nicks was examined by (i) expressing Apn1 (Δapn1/pAPN1), or (ii) expressing both Mag and Apn1 (Δapn1/pMAG/pAPN1) (Table 1).

(A ) Vkg-GFP accumulation in a shi i adipocyte (BM-40-SPARC>shi i ) expressing membrane marker myr-RFP.

Usually, the function π is built by "conjunction" of possibility functions of individual relations π i (δ i ) (expressing user-defined preference or priority on each individual constraint, in many cases in a problem-dependent way).

Animal breeding values a i were modelled in two parts: one (a0 i ) expressing the animal's average effect across environments and one (∑ j = 1 p (a ji ∗ P C jh ) ) that depended on the PC scores of the animal's herd, i.e., on the environment.

As discussed above, the latter event explains why TAP and MHC-I expressing tumor cells can prime a better a T cell response in peptide-based T cell priming.

As a single example, IFN-β response was reduced by ∼50% in cells co-transfected with an equimolar concentration of WT RIG-I and S183I RIG-I expressing vectors and further activated by these stimuli (n = 3, p<0.0001).

Expression plasmids pHA-MDA5 encoding human MDA5 fused to an N-terminal HA tag and pGFP-RIG-I expressing human RIG-I fused to the C terminus of EGFP were described previously [16].

By using the VSV-Np model antigen, we have demonstrated that DCs efficiently cross-present antigens from TAP and MHC-I expressing donor tumor cells or infected cells for T cell generation.

In summary, our results demonstrate for the first time that MHC-I/antigenic peptide complexes derived from TAP and MHC-I expressing cells but not TAP and MHC-I deficient cells can enhance T cell priming and subsequently increase the cytolytic activity of antigen specific T cell populations.